Covered recipient · General Payments record
RUSSELL DAMBRA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2025
$2,892.49
- Reported across 147 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.11 | 11 |
| Education | $45.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IBSA Pharma Inc. | $48.23 | 2 |
| Lilly USA, LLC | $45.00 | 1 |
| Novo Nordisk AS | $38.46 | 2 |
| Radius Health, Inc. | $28.41 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.89 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.31 | 1 |
| Ascendis Pharma Endocrinology Inc | $20.00 | 1 |
| Amgen Inc. | $17.84 | 1 |
| ABBVIE INC. | $17.06 | 1 |
| Antares Pharma, Inc. | $15.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.06 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201722117 | CMS |
| Amgen Inc. | $17.84 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228551254 | CMS |
| Antares Pharma, Inc. | $15.91 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235884284 | CMS |
| Ascendis Pharma Endocrinology Inc | $20.00 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237033467 | CMS |
| IBSA Pharma Inc. | $23.52 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211687511 | CMS |
| IBSA Pharma Inc. | $24.71 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211689244 | CMS |
| Lilly USA, LLC | $45.00 | 01/13/2025 | Education | Undisputed | 06/30/2026 | 1186939309 | CMS |
| Novartis Pharmaceuticals Corporation | $21.31 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200121622 | CMS |
| Novo Nordisk Inc | $20.59 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189166427 | CMS |
| Novo Nordisk Inc | $17.87 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188342758 | CMS |
| Radius Health, Inc. | $28.41 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249522085 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.89 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250174344 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.